Figure 4
Figure 4. Effect of fondaparinux or heparin on clotting induced by RecombiPlasTin or coagulation enzymes. After incubating 1/1500-diluted RecombiPlasTin, 0.13nM fXa, 5nM fIXa, 0.5nM fXIa, or 20nM fXIIa in plasma containing fondaparinux (closed circles) or heparin (open circles), at the indicated concentrations, for 10 minutes at 37°C, clotting was initiated by addition of CaCl2 to 20mM. For thrombin-initiated reactions, CaCl2 was omitted to avoid feedback activation of coagulation, and thrombin (fIIa) was added to 5nM after the 10-minute incubation at 37°C. Absorbance was monitored up to a maximum of 14 000 seconds, and time to clot was determined. The symbols represent the mean of ≥ 3 separate experiments, and the lines above and below the symbols reflect the SD. The arrows represent the contact, tissue factor, and common pathways of coagulation.

Effect of fondaparinux or heparin on clotting induced by RecombiPlasTin or coagulation enzymes. After incubating 1/1500-diluted RecombiPlasTin, 0.13nM fXa, 5nM fIXa, 0.5nM fXIa, or 20nM fXIIa in plasma containing fondaparinux (closed circles) or heparin (open circles), at the indicated concentrations, for 10 minutes at 37°C, clotting was initiated by addition of CaCl2 to 20mM. For thrombin-initiated reactions, CaCl2 was omitted to avoid feedback activation of coagulation, and thrombin (fIIa) was added to 5nM after the 10-minute incubation at 37°C. Absorbance was monitored up to a maximum of 14 000 seconds, and time to clot was determined. The symbols represent the mean of ≥ 3 separate experiments, and the lines above and below the symbols reflect the SD. The arrows represent the contact, tissue factor, and common pathways of coagulation.

Close Modal

or Create an Account

Close Modal
Close Modal